Pediatric Solid Tumor Physician

Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the excellence of our academic community.

The Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta and the Emory University Department of Pediatrics invites interested applicants for the position of Aflac Solid Tumor Clinician. The Aflac Cancer and Blood Disorders Center provides a rich and collaborative environment for basic clinical and translational research and has a diverse faculty. The Solid Tumor Program is an integral component of the Aflac Cancer and Blood Disorders Center and currently includes 9 faculty members 4 of whom are primarily basic/translational research-focused as well as 4 advance practice providers (APPs). Additionally the Solid Tumor Program partners closely with our surgical radiation oncology and radiology teams to provide comprehensive state-of-the-art care for pediatric and AYA solid tumor patients. Candidates will have a strong record of demonstrated clinical expertise caring for pediatric oncology patients particularly those with solid tumors. Clinical experience in treating patients on early phase clinical trials and clinical research interest focused on the development and leadership of early phase clinical trials is preferred. The Aflac Cancer and Blood Disorders Center has close affiliations with research investigators within the Winship Cancer Institute Emory University and the Georgia Institute of Technology and a willingness to collaborate across departmental or center boundaries is essential.

About the Aflac Cancer and Blood Disorders Center

The successful candidate will join one of the strongest pediatric hematology/oncology programs in the country.

• In 2024 the Aflac Cancer and Blood Disorders Center was ranked No. 12 in the nation for Pediatric Cancer by US News and World Report.
• The Aflac Cancer & Blood Disorders Center has 125 faculty members and approximately 50 APPs conducting basic translational and clinical research related to pediatric oncology and hematology disorders with expertise in leukemias lymphomas brain tumors neuroblastoma sarcomas rare tumors renal tumors CAR T-cell therapies hemoglobinopathies and hemophilia..
• Aflac is a major contributor to the success of the Childrens Oncology Group (COG) and is annually among the top 4 institutions in therapeutic and total enrollments. Additionally Aflac solid tumor faculty hold multiple leadership positions on clinical trials within disease-based committees and more broadly within COG.
• The Solid Tumor Program saw over 150 newly diagnosed solid tumor patients in 2024 including almost 50 patients with sarcomas and 25 with renal tumors.
• We have a large multi-disciplinary sarcoma program serving both pediatric and AYA patients which includes a Musculoskeletal Survivor Clinic.
• Our established Relapsed/Refractory Neuroblastoma Program has given over 100 MIBG infusions over the last 10 years and is one of the few MIBG treatment centers in the US with the ability to treat patients in the PICU allowing for more adequate sedation in younger patients.
• The Aflac Developmental Therapeutics Program offers a wide portfolio of clinical trials from cooperative groups industry partners and investigator-initiated studies and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN) NANT TACL and PBTC and our faculty have leadership roles within these cooperative groups. The novel translational research conducted by Aflac solid tumor researchers combined with strong industry relationships and philanthropic support in the Atlanta area makes for a ripe environment for the generation of investigator-initiated early phase clinical trials.
• The Aflac Pediatric Hematology/Oncology Fellowship Program accepts 6 fellows each year for intensive clinical and research training in Pediatric Hematology/Oncology with ample teaching opportunities for faculty.

The physician in this position will devote the majority of their effort to clinical responsibilities (0.6-0.8 clinical FTE) in the Aflac Cancer and Blood Disorders Center at Childrens Healthcare of Atlanta. Clinical coverage will be at Arthur M. Blank Hospital and will include both outpatient and inpatient responsibilities including call and may be adjusted depending on service needs. This physician will:

• Provide exemplary clinical service and assure that patients cared for by you receive only the highest quality care.
• In collaboration with program leaders contribute to and expand the clinical program and patient services in pediatric solid tumor and general oncology.
• Devote the remainder of their effort (amount dependent upon research interests and funding) to clinical research preferably with our Developmental Therapeutics Program.
• Play a role in the education and training program of the Pediatric Hem/Onc/BMT Division including access to and involvement with medical students residents fellows and occasionally physicians in practice.

Successful candidates will have:

• MD MD/PhD or DO degrees
• Must be board eligible or board certified in Pediatric Hematology-Oncology
• Must be currently licensed as a physician and eligible for licensure as a physician in the state of Georgia
• A history of clinical excellence/achievement
• Clinical research experience preferred with a focus on early phase clinical trials
• A strong history of mentorship of trainees to support growth in research and scholarship

Salary and rank of Assistant Professor Associate Professor or Professor at Emory University School of Medicine will be commensurate with experience and accomplishments.

Additional Details
Employment will be in the Emory Childrens Pediatric Institute. The Emory Childrens Pediatric Institute is an affiliation between Emory University and Childrens Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care conducting innovative basic science discovery and clinical research and coordinating exceptional education of the future healthcare workforce. Our physicians researchers and educators have created a model where leadership commitment and quality are fundamental components of success. Together we are transforming pediatrics by achieving new levels of clinical excellencedriven by research teaching and wellness. We look forward to our future together.

Emory is an equal opportunity employer and qualified applicants will receive consideration for employment without regard to race color religion sex national origin disability protected veteran status or other characteristics protected by state or federal law. Emory University does not discriminate in admissions educational programs or employment including recruitment hiring promotions transfers discipline terminations wage and salary administration benefits and training. Students faculty and staff are assured of participation in university programs and in the use of facilities without such discrimination. Emory University complies with Section 503 of the Rehabilitation Act of 1973 the Vietnam Era Veterans Readjustment Assistance Act and applicable executive orders federal and state regulations regarding nondiscrimination equal opportunity and affirmative action (for protected veterans and individuals with disabilities). Inquiries regarding this policy should be directed to the Emory University Department of Equity and Civil Rights Compliance 201 Dowman Drive Administration Building Atlanta GA 30322. Telephone: (V) (TDD).

Emory University is committed to providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to request a reasonable accommodation please contact the Department of Accessibility Services at (V) (TDD). Please note that one weeks advance notice is preferred.